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Alzheimer’s disease (AD) is the most common neurodegenerative disorder. Familial AD is caused by 
mutations in APP, PSEN1 and PSEN2, while individuals carrying the ε4 allele of Apolipoprotein E (ApoE) are at 
increased risk of AD. One of the neuropathologic feature of AD is represented by the extracellular deposition 
of β-amyloid (Aβ), deriving from the proteolysis of the Amyloid Precursor Peptide (APP) by presenilins 
(encoded by PSEN1 and PSEN2), the catalytic core of the γ-secretase complex. Aβ accumulation seems to be 
responsible for the pathogenesis, although lately this hypothesis is debated. Recent data suggest the 
involvement of the ApoE receptor, the Low-Density Lipoprotein Receptor-Related Protein memory in AD 
genesis. LRP8 is involved in neuronal migration, cell proliferation and memory and, like APP, is cleaved by γ–
secretase. We hypothesized that the expression levels and relative proteolytic processing of LRP8 may 
modulate and influence the AD phenotype, and the occurrence of neurodegeneration. To test our 
hypothesis, we used C.elegans to study in vivo the correlation among LRP8, PSEN and APP. We generated 
transgenics overexpressing in neurons human LRP8, as full-length or as fragmented proteins. These lines 
present a dose- dependent defect in development, locomotion and lifespan. Moreover, we showed PSEN 
involvement in LRP8 function, using a pharmacological and a genetic approach. The role of the different 
domains of hLRP8 in these phenotypes is under analysis and the impact on learning and APP proteolysis will 
be shown. 
 
